These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4192759)

  • 21. Content of IgG, IgA and IgM immunoglobulins in international units in normal and IgA-enriched gammaglobulins.
    Hristova G; Bozadjiev L; Guturanov P; Peeva Z; Dimitrova Z
    Dev Biol Stand; 1974; 27():54-7. PubMed ID: 4142776
    [No Abstract]   [Full Text] [Related]  

  • 22. Evidence to suggest that LATS protector stimulates the human thyroid gland.
    Adams DD; Kennedy TH
    J Clin Endocrinol Metab; 1971 Jul; 33(1):47-51. PubMed ID: 5558041
    [No Abstract]   [Full Text] [Related]  

  • 23. Changes in LATS and other thyoid autoantibody levels with therapy.
    Kilpatrick JA
    N Z Med J; 1974 Dec; 80(529):495-6. PubMed ID: 4532201
    [No Abstract]   [Full Text] [Related]  

  • 24. Quantitative estimation of human immunoglobulins. I. Estimation of IGG, IGA and IGM immunoglobulins by the method of simple radial immunodiffusion.
    Skvaril F; Rádl J
    J Hyg Epidemiol Microbiol Immunol; 1969; 13(1):107-17. PubMed ID: 4181518
    [No Abstract]   [Full Text] [Related]  

  • 25. Positive correlation of the long-acting thyroid stimulator (LATS) with the percentage of endogenously labelled 131 I triiodothyronine in the plasma of hyperthyroid patients.
    Emrich D; Albani M; zur Mühlen A von
    Acta Endocrinol (Copenh); 1971 Nov; 68(3):445-50. PubMed ID: 4107957
    [No Abstract]   [Full Text] [Related]  

  • 26. Thyrotoxicosis.
    Lancet; 1967 Dec; 2(7527):1186-7. PubMed ID: 4168385
    [No Abstract]   [Full Text] [Related]  

  • 27. [Histo-immunological detection of immunoglobulins IgG, IgM and IgA in serous papillary adenocarcinoma of the ovary].
    Montemagno U; Di Stefano M; Cardone A
    Boll Soc Ital Biol Sper; 1969 Nov; 45(21):1356-8. PubMed ID: 4196113
    [No Abstract]   [Full Text] [Related]  

  • 28. [Nature of "LATS" immunoglobulin with prolonged thyreotropic action and localization of its antigen].
    Benhamou-Glynn N
    Ann Inst Pasteur (Paris); 1970 Apr; 118(4):539-46. PubMed ID: 5421296
    [No Abstract]   [Full Text] [Related]  

  • 29. [On LATS (long-acting thyroid stimulator)].
    Miyai K
    Nihon Byori Gakkai Kaishi; 1967; 56():Suppl:379-86. PubMed ID: 4181809
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cytogenetic studies in patients with thyroiditis and LATS and antibody-positive hyperthyroidism].
    Tolksdorf M; Schemmel K; Mühlenstedt D; Uthgenannt H; Müller W
    Schweiz Med Wochenschr; 1969 Jul; 99(30):1082-5. PubMed ID: 5351142
    [No Abstract]   [Full Text] [Related]  

  • 31. EVIDENCE OF A NORMALLY FUNCTIONING PITUITARY TSH SECRETION MECHANISM IN A PATIENT WITH A HIGH BLOOD LEVEL OF LONG-ACTING THYROID STIMULATOR.
    ADAMS DD; KENNEDY TH
    J Clin Endocrinol Metab; 1965 May; 25():571-6. PubMed ID: 14313750
    [No Abstract]   [Full Text] [Related]  

  • 32. Electrophoretic and quantitative studies on serum proteins in thyroid diseases.
    Miklaszewska M; Checińska Z
    Mater Med Pol; 1973; 5(4):250-4. PubMed ID: 4133321
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies.
    Pinchera A; Liberti P; Martino E; Fenzi GF; Grasso L; Rovis L; Baschieri L; Doria G
    J Clin Endocrinol Metab; 1969 Feb; 29(2):231-8. PubMed ID: 4179303
    [No Abstract]   [Full Text] [Related]  

  • 34. Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis.
    Hoffman WH; Sahasrananan P; Ferandos SS; Burek CL; Rose NR
    J Clin Endocrinol Metab; 1982 Feb; 54(2):354-6. PubMed ID: 6119322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of surgery and 131-I therapy for hyperthyroidism in the etiology of thyroid carcinoma.
    Ashkar FS; Miale A; Smoak WM; Weinstein MB
    South Med J; 1973 Sep; 66(9):1014-6. PubMed ID: 4733573
    [No Abstract]   [Full Text] [Related]  

  • 36. Radioactive iodine therapy for progressive malignant exophthalmos.
    Bauer FK; Catz B
    Acta Endocrinol (Copenh); 1966 Jan; 51(1):14-22. PubMed ID: 5951904
    [No Abstract]   [Full Text] [Related]  

  • 37. Ophthalmopathy without hyperthyroidism in patients with histologic Hashimoto's thyroiditis.
    Wyse EP; McConahey WM; Woolner LB; Scholz DA; Kearns TP
    J Clin Endocrinol Metab; 1968 Nov; 28(11):1623-9. PubMed ID: 5754841
    [No Abstract]   [Full Text] [Related]  

  • 38. [Histoimmunological research on IgM, IgG and IgA immunoglobulines in post-molar choricoarcinoma].
    Montemagno U; Di Stefano M
    Boll Soc Ital Biol Sper; 1968 Feb; 44(3):167-9. PubMed ID: 4176913
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies of serum long-acting thyroid stimulator (LATS) in relation to exophthalmos after therapy for thyrotoxicosis.
    Hetzel BS; Mason EK; Wang HK
    Australas Ann Med; 1968 Nov; 17(4):307-11. PubMed ID: 4178378
    [No Abstract]   [Full Text] [Related]  

  • 40. Cellular autoimmune reactions following radioiodine treatment for hyperthyroidism.
    Einhorn N; Wasserman J; Packalén T
    Acta Radiol Ther Phys Biol; 1970 Jun; 9(3):225-32. PubMed ID: 4916356
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.